Skin Prick Tests With AllerT in Subjects Allergic to Birch Pollen

NCT01719133 ↗

Phase 1 Completed 20 enrolled Anergis

NaSingle-groupOpen-labelScreening

Summary

Assessment of skin reactivity by skin prick tests to synthetic peptides derived from the major birch allergen bet v 1, in subjects allergic to birch pollen.

Timeline

Start: 2008-02
Primary completion: 2008-03
Completion: 2008-06

Publications

Pellaton C, Perrin Y, Boudousquie C, Barbier N, Wassenberg J, Corradin G, Thierry AC, Audran R, Reymond C, Spertini F. Novel birch pollen specific immunotherapy formulation based on contiguous overlapping peptides. Clin Transl Allergy. 2013 Jun 1;3(1):17. doi: 10.1186/2045-7022-3-17.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	AllerT1	Peptide	—	Other
Subject	AllerT2	Peptide	—	Other
Subject	AllerT3	Peptide	—	Other
Subject	AllerT4	Peptide	—	Other
Subject	AllerT5	Peptide	—	Other
Subject	mix of AllerT1-T2-T3	Peptide	—	Other
Subject	mix of AllerT4-T5	Unknown	—	Other
Background	Histamine	Small molecule	—	Other

Skin Prick Tests With AllerT in Subjects Allergic to Birch Pollen

Summary

Timeline

Publications

Drugs

Indications